Weijing Sun

12PUBLICATIONS
34CO-AUTHORS
Cancer diagnosisChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 28, 2026
Pancreatic Acinar Cell Carcinoma: A Rare Pancreatic Malignancy with Distinct Biology and Emerging Therapeutic Opportunities.

|Jul 02, 2025
Sintilimab and anlotinib with gemcitabine plus cisplatin in advanced biliary tract cancer: SAGC a randomized phase 2 trial.

Jingjing Li, Shurui Zhou, Xiaoqing Xu

|Apr 12, 2025
Gut commensal Bifidobacterium-derived extracellular vesicles modulate the therapeutic effects of anti-PD-1 in lung cancer.

Ranjan Preet, Md Atiqul Islam, Jiyoung Shim

|Feb 20, 2024
Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort.

Anwaar Saeed, Robin Park, Harsh Pathak

|Sep 28, 2023
Circulating Tumor Cell Subpopulations Predict Treatment Outcome in Pancreatic Ductal Adenocarcinoma (PDAC) Patients.

Ian M Freed, Anup Kasi, Oluwadamilola Fateru

|Jun 16, 2023
A phase II study of perioperative pembrolizumab plus mFOLFOX in patients with potentially resectable esophagus, gastroesophageal junction (GEJ), and stomach adenocarcinoma.

Weijing Sun, Nirmal Veeramachaneni, Raed Al-Rajabi

Pageof 2

Frequent Collaborators

3 joint publications

Joaquina Celebre Baranda

2 joint publications

Andrew K Godwin

1 joint publications

Carissa A Low

1 joint publications

Anind K Dey